Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

Stößel A, Brox R, Purkayastha N, Hübner H, Hocke C, Prante O, Gmeiner P.

Bioorg Med Chem. 2017 Jul 1;25(13):3491-3499. doi: 10.1016/j.bmc.2017.04.036. Epub 2017 Apr 29.

PMID:
28495386
2.

Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.

Gaiser EC, Gallezot JD, Worhunsky PD, Jastreboff AM, Pittman B, Kantrovitz L, Angarita GA, Cosgrove KP, Potenza MN, Malison RT, Carson RE, Matuskey D.

Neuropsychopharmacology. 2016 Dec;41(13):3042-3050. doi: 10.1038/npp.2016.115. Epub 2016 Jul 4.

3.

Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine.

Siciliano CA, Ferris MJ, Jones SR.

Eur J Neurosci. 2015 Aug;42(4):2091-6. doi: 10.1111/ejn.12970. Epub 2015 Jun 28.

4.

Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats.

Townsend EA, Beloate LN, Huskinson SL, Roma PG, Freeman KB.

Physiol Behav. 2015 May 1;143:136-41. doi: 10.1016/j.physbeh.2015.03.002. Epub 2015 Mar 3.

5.

Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.

Le Foll B, Di Ciano P.

Eur Neuropsychopharmacol. 2015 Sep;25(9):1401-9. doi: 10.1016/j.euroneuro.2014.08.017. Epub 2014 Sep 16. Review.

6.

Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity.

Savage SW, Zald DH, Cowan RL, Volkow ND, Marks-Shulman PA, Kessler RM, Abumrad NN, Dunn JP.

Obesity (Silver Spring). 2014 Jun;22(6):1452-7. doi: 10.1002/oby.20690. Epub 2014 Feb 11.

7.

Systemic treatment with D-fenfluramine, but not sibutramine, blocks cue-induced reinstatement of food-seeking behavior in the rat.

Pratt WE, Ford RT.

Neurosci Lett. 2013 Nov 27;556:232-7. doi: 10.1016/j.neulet.2013.10.030. Epub 2013 Oct 22.

8.

Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

Neisewander JL, Cheung TH, Pentkowski NS.

Neuropharmacology. 2014 Jan;76 Pt B:301-19. doi: 10.1016/j.neuropharm.2013.08.014. Epub 2013 Aug 23. Review.

9.

Electroacupuncture reduces cocaine-induced seizures and mortality in mice.

Chen YH, Ivanic B, Chuang CM, Lu DY, Lin JG.

Evid Based Complement Alternat Med. 2013;2013:134610. doi: 10.1155/2013/134610. Epub 2013 Apr 17.

10.

A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.

Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, Arbeláez AM, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T.

Synapse. 2013 Nov;67(11):748-56. doi: 10.1002/syn.21680. Epub 2013 May 30.

11.

Cocaine self-administration in dopamine D₃ receptor knockout mice.

Caine SB, Thomsen M, Barrett AC, Collins GT, Grundt P, Newman AH, Butler P, Xu M.

Exp Clin Psychopharmacol. 2012 Oct;20(5):352-63. doi: 10.1037/a0029135. Epub 2012 Aug 6.

12.

The effects of ghrelin on energy balance and psychomotor activity in a goldfish model: an overview.

Kang KS, Yahashi S, Matsuda K.

Int J Pept. 2011;2011:171034. doi: 10.1155/2011/171034. Epub 2011 May 24.

13.

Imaging of brain dopamine pathways: implications for understanding obesity.

Wang GJ, Volkow ND, Thanos PK, Fowler JS.

J Addict Med. 2009 Mar;3(1):8-18. doi: 10.1097/ADM.0b013e31819a86f7.

14.

Bulimia nervosa and evidence for striatal dopamine dysregulation: a conceptual review.

Broft AI, Berner LA, Martinez D, Walsh BT.

Physiol Behav. 2011 Jul 25;104(1):122-7. doi: 10.1016/j.physbeh.2011.04.028. Epub 2011 Apr 27. Review.

15.

Current and future drug targets in weight management.

Witkamp RF.

Pharm Res. 2011 Aug;28(8):1792-818. doi: 10.1007/s11095-010-0341-1. Epub 2010 Dec 23. Review.

16.

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Heidbreder CA, Newman AH.

Ann N Y Acad Sci. 2010 Feb;1187:4-34. doi: 10.1111/j.1749-6632.2009.05149.x. Review.

17.

Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.

Palmatier MI, Levin ME, Mays KL, Donny EC, Caggiula AR, Sved AF.

Psychopharmacology (Berl). 2009 Dec;207(3):381-90. doi: 10.1007/s00213-009-1666-5. Epub 2009 Sep 17.

18.

The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Achat-Mendes C, Platt DM, Newman AH, Spealman RD.

Psychopharmacology (Berl). 2009 Sep;206(1):73-84. doi: 10.1007/s00213-009-1581-9. Epub 2009 Jun 10.

19.

Obesity: increasing awareness of novel environmental factors.

Niswender KD, Beech BM.

Diabetes. 2008 Jul;57(7):1786-7. doi: 10.2337/db08-0527. No abstract available.

Supplemental Content

Support Center